Treatment rationale and design of the induction chemotherapy and adjuvant thoracic radiation in resectable N2-3A/3B non-small cell lung cancer (ICAT) study

BACKGROUND: The optimal treatment strategy for stage N2–3A/3B non-small cell lung cancer (NSCLC) remains controversial owing to its heterogeneity. Although multimodal therapy is considered the standard therapeutic approach for stage N2–3A/3B resectable NSCLC patients, the optimal combination strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsunezuka, Hiroaki, Inoue, Masayoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635234/
https://www.ncbi.nlm.nih.gov/pubmed/31277165
http://dx.doi.org/10.1097/MD.0000000000016298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635234/
https://www.ncbi.nlm.nih.gov/pubmed/31277165
http://dx.doi.org/10.1097/MD.0000000000016298

Ejemplares similares